2002
DOI: 10.4049/jimmunol.168.11.5409
|View full text |Cite
|
Sign up to set email alerts
|

Recycling CD1d1 Molecules Present Endogenous Antigens Processed in an Endocytic Compartment to NKT Cells

Abstract: Mouse CD1d1 molecules present endogenous glycolipids to NKT cells. Although glycolipid presentation requires CD1d1 transport through the endocytic pathway, the processing requirements for such endogenous Ag presentation by CD1d1 molecules are undefined. We examined CD1d1 Ag presentation to NKT cells by disrupting endocytic trafficking and function in cells expressing normal and mutated CD1d1 expressed by recombinant vaccinia viruses. Consistent with previous studies, we found that preventing CD1d1 localization… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

8
169
0
1

Year Published

2005
2005
2017
2017

Publication Types

Select...
6
1

Relationship

3
4

Authors

Journals

citations
Cited by 111 publications
(178 citation statements)
references
References 58 publications
8
169
0
1
Order By: Relevance
“…These results are in accordance with those shown by Prigozy et al [16], and imply that GSL with more than one carbohydrate moiety attached to the ceramide bind to cell surface CD1d, but are endocytosed and processed to a simple GSL before being presented to NKT cells. The anti-mouse-CD1d monoclonal antibody 1H6 [17] (but not the negative control Ab) completely blocked the bacterial GSL presentation to NKT cells, confirming the CD1d-dependence of GSL recognition (Fig. 3).…”
Section: Resultssupporting
confidence: 59%
See 2 more Smart Citations
“…These results are in accordance with those shown by Prigozy et al [16], and imply that GSL with more than one carbohydrate moiety attached to the ceramide bind to cell surface CD1d, but are endocytosed and processed to a simple GSL before being presented to NKT cells. The anti-mouse-CD1d monoclonal antibody 1H6 [17] (but not the negative control Ab) completely blocked the bacterial GSL presentation to NKT cells, confirming the CD1d-dependence of GSL recognition (Fig. 3).…”
Section: Resultssupporting
confidence: 59%
“…We have previously shown that the pharmacological inhibitors including chloroquine [18,19], primaquine, and bafilomycin A1 [20], that inhibit the endosomal recycling pathway and lysosomal enzyme activities by different modes of action, inhibit antigen-presentation by CD1d without altering its cell surface levels [1,17]. We thus assessed the requirement for intracellular processing of Sphingomonas GSL.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Further investigation will be required to determine the cause as well as the significance of this difference; however, we suspect it could be due to a differential effect of the MIR proteins on CD1d loading of endogenously versus exogenously derived antigens. CD1d molecules traffic extensively through the endocytic system (49)(50)(51)(52)(53) and are capable of presenting both exogenously derived (54) and endogenously derived antigens (46,55). However, it is not clear in which compartments the relevant physiological ligands of CD1d-restricted T cells are loaded, and it is possible that exogenous and endogenous cellular lipids may be loaded at different sites.…”
Section: Discussionmentioning
confidence: 99%
“…In order to determine the role of apoptosis in CD1d-mediated antigen presentation to NKT cells, murine LMTK fibroblasts transfected with the mouse cd1d1 cDNA (LMTK-CD1d1 cells) 26 were treated with various concentrations of the glycolipid biosynthesis inhibitors, PPMP, FB1 and NB-DGJ, and co-cultured with NKT cells. It is known that PPMP (but not FB1 or NB-DGJ) treatment results in an increased level of intracellular ceramide, leading to apoptosis, whereas FB1 inhibits the biosynthesis of the ceramide in the treated cells.…”
Section: Apoptosis Induction Inhibits Cd1d-mediated Antigen Presentationmentioning
confidence: 99%